[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.202.12. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
January 1974

The Use of Cyclazocine in Treating Narcotic Addicts in a Low-Intervention Setting

Author Affiliations

New Haven, Conn
From the Department of Psychiatry, Yale University School of Medicine and the Drug Dependence Unit, Connecticut Mental Health Center, New Haven.

Arch Gen Psychiatry. 1974;30(1):37-42. doi:10.1001/archpsyc.1974.01760070023004
Abstract

This study evaluated the clinical efficacy of cyclazocine when used as part of a direct-service drug-abuse program characterized by relatively low-treatment intervention. Standard induction and maintenance schedules were devised and procedures were developed to evaluate results.

Twenty-seven patients were administered cyclazocine over a tenmonth period with 42% being retained. Results suggest that, although cyclazocine was accepted by a majority (75%) of the sample, the nature and extent of side effects during induction may limit its usefulness of a larger scale. The overall program design holds promise as a model for future use of narcotic antagonists.

×